| Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-01-15 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sold | 100,000 | $28.73 | $2.9M |
| 2026-01-14 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sold | 84,803 | $28.17 | $2.4M |
| 2025-12-23 | CLARK IAN T Director | Sold | 234,896 | $29.85 | $7.0M |
| 2025-12-23 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sold | 43,729 | $30.40 | $1.3M |
| 2025-12-23 | Zojwalla Naseem Chief Medical Officer | Sold | 256,588 | $27.89 | $7.2M |
| 2025-01-13 | Bain Capital Life Sciences Fund IV, L.P. 10% owner | Bought | 300,000 | $5.76 | $1.7M |
| 2024-12-18 | Graham G. Walmsley Director | Bought | 700,761 | $6.75 | $4.7M |
| 2024-12-18 | Graham G. Walmsley Director | Sold | 700,761 | $6.75 | $4.7M |
| 2024-12-17 | Graham G. Walmsley Director | Bought | 700,761 | $6.75 | $4.7M |
| 2024-12-17 | Graham G. Walmsley Director | Sold | 700,761 | $6.75 | $4.7M |
| 2024-11-26 | Graham G. Walmsley Director | Sold | 1,175,000 | $14.85 | $17.4M |
| Insider | Role | Buys | Total bought |
|---|---|---|---|
| Graham G. Walmsley | Director | 2 | $9.5M |
| Bain Capital Life Sciences Fund IV, L.P. | 10% owner | 1 | $1.7M |
Every insider buy and sell for OLMA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.
Open the browserFree sample